COVID-19 (peds): Difference between revisions
No edit summary |
|||
| Line 25: | Line 25: | ||
==References== | ==References== | ||
<references/> | <references/> | ||
==CHILDREN== | |||
=== Epidemiology among Children === | |||
*2% of cases amongst < 2 years of age (NOTE: 13% in only one major city in China) | |||
*Mostly because of household exposures (from adults) | |||
*Vast majority of cases in US are in adults | |||
=== Symptoms in children === | |||
*Fever (50-80%), cough, congestion, rhinorrhea, sore throat | |||
*GI in some cases (at least one case with GI sx first then respiratory symptoms after) | |||
*50% of peds cases with fever, 30% with cough | |||
Disease Course | |||
*Mostly mild (for unclear reasons) except for only 2 cases: | |||
**13 month developed ARDS and ICU care | |||
**3 year old needed ICU | |||
*No deaths in children under 10 (from china so far) | |||
*Radiographic: same as adults (bilateral, pulmonary lesions, GGO; some with unilateral). | |||
=== Q&A === | |||
*Are children with underlying medical conditions (asthma, or special healthcare needs) at increased risk? | |||
** No data exists | |||
=== Labs === | |||
*Mild CRP or AST elevations | |||
*No consistency on WBC (mild leukocytosis, leukopenia) | |||
*Few coinfections have been reported (with RSV, Influenza, mycoplasma). | |||
**Coinfection unlikely (but possible) at this time | |||
Treatment | |||
*Supportive care, isolation at home best unless needing hospitalisation | |||
*Infection prevention and support!!! handwashing and PPE | |||
*No remdesavir trials in children | |||
=== Transmission in Paediatrics === | |||
*Shedding for longer than adults (up to 22 days, some up to 30 days) | |||
*Mostly goes from adults to children (not the other way around) | |||
=== HCW pediatric visits=== | |||
*CDC recommends decreased face-to-face triage | |||
*nurse -directed triage and telehealth visits | |||
Revision as of 11:32, 21 March 2020
Background
Clinical Features
Differential Diagnosis
Evaluation
Management
Disposition
See Also
COVID-19 Pages
- COVID-19 (main)
External Links
References
CHILDREN
Epidemiology among Children
- 2% of cases amongst < 2 years of age (NOTE: 13% in only one major city in China)
- Mostly because of household exposures (from adults)
- Vast majority of cases in US are in adults
Symptoms in children
- Fever (50-80%), cough, congestion, rhinorrhea, sore throat
- GI in some cases (at least one case with GI sx first then respiratory symptoms after)
- 50% of peds cases with fever, 30% with cough
Disease Course
- Mostly mild (for unclear reasons) except for only 2 cases:
- 13 month developed ARDS and ICU care
- 3 year old needed ICU
- No deaths in children under 10 (from china so far)
- Radiographic: same as adults (bilateral, pulmonary lesions, GGO; some with unilateral).
Q&A
- Are children with underlying medical conditions (asthma, or special healthcare needs) at increased risk?
- No data exists
Labs
- Mild CRP or AST elevations
- No consistency on WBC (mild leukocytosis, leukopenia)
- Few coinfections have been reported (with RSV, Influenza, mycoplasma).
- Coinfection unlikely (but possible) at this time
Treatment
- Supportive care, isolation at home best unless needing hospitalisation
- Infection prevention and support!!! handwashing and PPE
- No remdesavir trials in children
Transmission in Paediatrics
- Shedding for longer than adults (up to 22 days, some up to 30 days)
- Mostly goes from adults to children (not the other way around)
HCW pediatric visits
- CDC recommends decreased face-to-face triage
- nurse -directed triage and telehealth visits